Manonthestreet
Diamond Member
- May 20, 2014
- 34,711
- 22,982
- 1,945
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Temperature-stable tuberculosis vaccine safe, prompts immune response in first-in-human trial
More testing to be done but nobody died or lost a limb.........no mrna ,,,,,,what a concept
More testing to be done but nobody died or lost a limb.........no mrna ,,,,,,what a concept
